[HTML][HTML] Factors affecting visual outcomes in patients with diabetic macular edema treated with ranibizumab
Eye, 2014•nature.com
Factors affecting visual outcomes in patients with diabetic macular edema treated with
ranibizumab | Eye Skip to main content Thank you for visiting nature.com. You are using a
browser version with limited support for CSS. To obtain the best experience, we recommend
you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the
meantime, to ensure continued support, we are displaying the site without styles and JavaScript.
Advertisement Eye View all journals Search My Account Explore content About the journal …
ranibizumab | Eye Skip to main content Thank you for visiting nature.com. You are using a
browser version with limited support for CSS. To obtain the best experience, we recommend
you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the
meantime, to ensure continued support, we are displaying the site without styles and JavaScript.
Advertisement Eye View all journals Search My Account Explore content About the journal …
Abstract
Purpose
To identify factors associated with visual outcomes in patients with diabetic macular edema (DME) treated with ranibizumab (RBZ) in the Ranibizumab for Edema of the mAcula in Diabetes—Protocol 2 (READ-2) Study.
nature.com